Sep 13, 2022 / 06:05PM GMT
Erin Elizabeth Wilson Wright - Morgan Stanley, Research Division - Equity Analyst
Hi, everyone. Good afternoon. My name is Erin Wright. I'm the Morgan Stanley Healthcare Services and Distribution analyst, which -- it also includes animal health in there. I'm pleased to have with us Zoetis' CFO, Wetteny Joseph with us here today. Zoetis is the world's largest, most diversified manufacturer of animal health products globally.
For important disclosures, please see Morgan Stanley research disclosure website at morganstanley.com. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, I think we'll just kick it off with Q&A, if that works for you.
Questions and Answers:
Wetteny N. Joseph - Zoetis Inc. - Executive VP & CFOIt works.
Erin Elizabeth Wilson Wright - Morgan Stanley, Research Division - Equity Analyst
Yes. So let's start with 2022. And you narrowed your guidance from a top line perspective operationally to 9.5% to 10.5%, excluding